As it leads the fight against the opioid crisis, investee company PneumoWave has achieved ISO 13485:2016 certification and registered a version of its technology as a Class 1 UKCA device. These milestones demonstrate PneumoWave’s commitment to developing safe, reliable and effective solutions for people at risk of opioid-related harm as well as furthering its goal of delivering innovative, real-time monitoring technology.
Read the full Press Release